BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 11003621)

  • 1. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8.
    Kim YM; Kim TH; Chung HT; Talanian RV; Yin XM; Billiar TR
    Hepatology; 2000 Oct; 32(4 Pt 1):770-8. PubMed ID: 11003621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells.
    Partheniou F; Kelsey SM; Srinivasula SM; Newland AC; Alnemri ES; Jia L
    Biochem Biophys Res Commun; 2001 Sep; 287(1):181-9. PubMed ID: 11549272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
    Perkins CL; Fang G; Kim CN; Bhalla KN
    Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway.
    Oh SH; Lee BH; Lim SC
    Biochem Pharmacol; 2004 Nov; 68(9):1845-55. PubMed ID: 15450950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release.
    Slee EA; Keogh SA; Martin SJ
    Cell Death Differ; 2000 Jun; 7(6):556-65. PubMed ID: 10822279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ; Ng LT; Lin CC
    Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent.
    Werneburg N; Guicciardi ME; Yin XM; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G436-43. PubMed ID: 15075251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP.
    Oh HY; Namkoong S; Lee SJ; Por E; Kim CK; Billiar TR; Han JA; Ha KS; Chung HT; Kwon YG; Lee H; Kim YM
    Cell Death Differ; 2006 Mar; 13(3):512-23. PubMed ID: 16167066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y; Eid MA; Lewis RW; Kumar MV
    Cell Signal; 2005 Feb; 17(2):243-51. PubMed ID: 15494215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N; El-Deiry WS
    Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells.
    Chen J; Mehta JL; Haider N; Zhang X; Narula J; Li D
    Circ Res; 2004 Feb; 94(3):370-6. PubMed ID: 14684629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis.
    Kim JY; Kim YH; Chang I; Kim S; Pak YK; Oh BH; Yagita H; Jung YK; Oh YJ; Lee MS
    Oncogene; 2002 May; 21(20):3139-48. PubMed ID: 12082629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
    Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis is dependent on activation of cysteine and serine proteases.
    Park IC; Park MJ; Woo SH; Lee KH; Lee SH; Rhee CH; Hong SI
    Cytokine; 2001 Aug; 15(3):166-70. PubMed ID: 11554786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme).
    Kim YM; Talanian RV; Li J; Billiar TR
    J Immunol; 1998 Oct; 161(8):4122-8. PubMed ID: 9780184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.